Satish Garg, MD
Chief, Young Adult Clinics
Professor of Pediatrics & Medicine
Microvascular complications of type I diabetes, with emphases on:
- the recognition of factors responsible for early diabetic retinopathy and diabetic nephropathy
- clinical trials of medications to possibly reverse early changes in eyes and kidneys
- the definition of the early course of microangiopathy
- the evaluation of new, more rapid means of monitoring albumin excretion rates to assess kidney function
Evaluation and clinical use of new insulin analogues (short and long acting) as tools for achieving improved glycemic control in patients with type I diabetes.
Utilization of new insulin administration devices in the treatment of type I diabetes (pulmonary delivery of insulin and buccal delivery of insulin).
Glucose sensors: non-invasive glucose monitoring devices (Glucowatch, infrared ray, continuous subcutaneous glucose sensors).